Skip to main content

Arcus Biosciences

Arcus Biosciences Inc is a clinical-stage biopharmaceutical enterprise headquartered in Hayward, California. The company specializes in the discovery and development of innovative therapies for cancer, with a pipeline focusing on small-molecule inhibitors and monoclonal antibodies targeting key tumor pathways. Its therapeutic candidates aim to modulate immune response and enhance efficacy in oncology indications. Principal revenue is currently earned through strategic pharmaceutical partnerships, licensing agreements, and capital financing arrangements as its drug candidates advance through clinical trials. Arcus Biosciences Inc is publicly listed on the New York Stock Exchange.

7 of the funds FundTelligence covers report a position in Arcus Biosciences.

Legal name
Arcus Biosciences Inc
Sector
Health Care
Country
United States
Funds holding it
7

Funds holding Arcus Biosciences

Loading...